Albemarle (ALB) Tops Q3 EPS by 1c; Trims FY15 Outlook

Albemarle (NYSE: ALB) reported Q3 EPS of $0.90, $0.01 better than the analyst estimate of $0.89. Revenue for the quarter came in at $905.1 million versus the consensus estimate of $947.03 million.

Albemarle sees FY2015 EPS of $3.65-$3.80, versus prior guidance of $3.65-$4.05 and the consensus of $3.85.

For earnings history and earnings-related data on Albemarle (ALB) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'